Loading clinical trials...

Tender Loving Care for Recurrent Pregnancy Loss | Clinical Trials | Clareo Health

RECRUITINGNA

Tender Loving Care for Recurrent Pregnancy Loss

A Single-arm Trial of a Web Based TLC (Tender Loving Care) Platform to Psychologically Support Patients With Recurrent Pregnancy Loss

NCT06182878•Walter Reed National Military Medical Center

View on ClinicalTrials.gov

Summary

The goal of this investigational study is to evaluate participation in a weekly, interactive, tender loving care messaging platform impact on pregnancy outcomes in patients with recurrent pregnancy loss. The main questions it aims to answer are: (1) does participation in weekly, interactive tender loving care messages increase live birth rates in patients with recurrent pregnancy loss? (2) Does participation in weekly, interactive tender loving care messages increase patients' quality of life? Does participation in weekly, interactive tender loving care messages decrease patients' depressive symptoms? Participants will be asked to interact with weekly messages providing prenatal counseling and support. Additionally, patients will be asked to complete the fertility quality of life survey several times over the course of the pregnancy.

Detailed Description

Participants will be asked to interact with weekly messages providing prenatal counseling and support. Additionally, patients will be asked to complete the fertility quality of life survey several times over the course of the pregnancy.

Eligibility

Age

18 - 44 years

Sex

FEMALE

Healthy Volunteers

Yes

Inclusion Criteria

•Pregnant individuals receiving their prenatal care at WRNMMC
•Able to speak and understand English
•Less than or equal to 10+0 weeks gestation by last menstrual period (LMP) or dating ultrasound at the time of enrollment
•At least two prior pregnancy losses. Pregnancy losses must be confirmed with laboratory criteria confirming a positive pregnancy test in the military electronic medical record with subsequent resolution (resolution may be reported by patient), or with ultrasound criteria demonstrating an intrauterine gestational sac with subsequent resolution (resolution may be reported by patient).

Exclusion Criteria

•Age less than 18 years and older than 44 at time of enrollment
•Unable to speak or understand English
•Current smoker or tobacco use within 30 days
•History of uterine anomaly, coagulopathy, balanced translocation, endometrial polyps, submucosal fibroids, pathology confirmed acute or chronic endometritis, hydrosalpinx, history of Asherman syndrome, poorly controlled endocrinopathies, HIV infection
•History of gonadotoxic therapy or cancerous condition of the female reproductive tract
•Suspicion for or confirmation of an ectopic pregnancy

Locations (1)

Walter Reed National Military Medical Center

Bethesda, Maryland, United States

Key Dates

Start Date

January 1, 2024

Primary Completion Date

December 1, 2025

Completion Date

December 1, 2025

Last Updated

May 1, 2024

Enrollment

ESTIMATED participants

Conditions

Recurrent Pregnancy Loss

Interventions

Tender loving care intervention

BEHAVIORAL

Contacts

David Boedeker, DO

CONTACT

301-400-2140 david.h.boedeker.mil@health.mil

Kiley Hunkler, MD

CONTACT

301-400-2140 kiley.f.hunkler.mil@health.mil

Noninvasive Implantation Potential vs Morphology-Based Selection in IVF Single Blastocyst Transfer

NCT07461077

Advanced AgeRecurrent Pregnancy Loss(RPL)+3 more

View study

COMPLETEDNA

Sperm DNA Fragmentation in Recurrent Pregnancy Loss

NCT02572154

RECURRENT PREGNANCY LOSS

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 1, 2024Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Tender Loving Care for Recurrent Pregnancy Loss

Inclusion Criteria

Exclusion Criteria

Noninvasive Implantation Potential vs Morphology-Based Selection in IVF Single Blastocyst Transfer

Sperm DNA Fragmentation in Recurrent Pregnancy Loss

Treatment of Recurrent Pregnancy Loss Using Mesenchymal Stem Cells

Study of the Role of Tissular Maternofetal Alloimmunization in Placentation Pathologies

TNFα and MFG-E8: Novel Biomarkers to Predict Implantation Failure

A Multi-center, Placebo-controlled Study to Evaluate NT100 in Pregnant Women With a History of Unexplained Recurrent Pregnancy Loss (RPL)